We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Eric Nemec II

Eric C Nemec II PharmD, MEHP, BCPS

Director of Research & Assessment, Clinical Associate Professor, Sacred Heart University; Fairfield, Connecticut; Sr. Educational Advisor, Johns Hopkins University, Baltimore, Maryland; Pharmacist, Stamford Health, Stamford, Connecticut

Dr. Eric Nemec is originally from Pittsburgh, Pennsylvania, where he received his Doctor of Pharmacy degree from the Mylan School of Pharmacy at Duquesne University. He then went on to complete a PGY-1 residency in Pharmacy Practice and a PGY-2 residency in Pharmacy Informatics at Yale-New Haven Hospital.  Dr. Nemec also earned a Master of Education in the Health Professions degree with a concentration in educational research and a Post-Master’s Certificate of Evidence-Based Teaching in the Health Professions from Johns Hopkins University. 

Dr. Nemec has a decade of experience in graduate health education and is currently the Director of Research & Assessment and a Clinical Associate Professor at the Sacred Heart University Physician Assistant Studies Program in Fairfield, CT. He is a Board-Certified Pharmacotherapy Specialist and in addition to his academic responsibilities, he practices as a clinical pharmacist at Stamford Hospital in Stamford, CT. Dr. Nemec resides in Trumbull, CT with his wife and two children.

Disclosures

The information contained in this commentary is free of commercial bias and the author has no related vested financial interest in any capacity, inclusive of shareholder, recipient of research grants, consulting, or advisory committees.

Recent Contributions to PracticeUpdate:

  1. Comparing Oral Anticoagulants in Patients With Chronic Kidney Disease
  2. Direct Oral Anticoagulants Are Safer Than Vitamin K Antagonists in Ischemic Stroke Patients With Atrial Fibrillation
  3. Dabigatran for Prevention of Stroke After Embolic Stroke of Undetermined Source

Most Read This Week

Recently Updated